1,705
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Isolation, crystal structure determination and cholinesterase inhibitory potential of isotalatizidine hydrate from Delphinium denudatum

, , , , , , & show all
Pages 680-686 | Received 19 Jun 2016, Accepted 19 Sep 2016, Published online: 29 Dec 2016

References

  • Alam M, Khan A, Wadood A, Khan A, Bashir S, Aman A, Jan AK, Rauf A, Ahmad B, Khan AR. 2016. Bioassay-guided isolation of sesquiterpene coumarins from Ferula narthex Bioss: a new anticancer agent. Front Pharmacol. 7:26–32.
  • Altomare A, Burla MC, Camalli M, Cascarano GL, Giacovazzo C, Guagliardi A, Moliterni AG, Polidori G, Spagna R. 1999. SIR97: a new tool for crystal structure determination and refinement. J App Cryst. 32:115–119.
  • Arendt T, Brückner MK, Lange M, Bigl V. 1992 . Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development-a study of molecular forms. Neurochem Int. 21:381–396.
  • Atta-ur-Rahman, Fatima N, Akhtar F, Choudhary MI, Khalid A. 2000. New norditerpenoid alkaloids from Aconitum falconeri. J Nat Prod. 63:1393–1395.
  • Atta-ur-Rahman, Nasreen A, Akhtar F, Shekhani MS, Clardy J, Parvez M, Choudhary MI. 1997. Antifungal diterpenoid alkaloids from Delphinium denudatum. J Nat Prod. 60:472–474.
  • Atta-ur-Rahman, Zaheer-ul-Haq, Khalid A, Anjum S, Khan MR, Choudhary MI. 2002. Pregnane-type steroidal alkaloids of Sarcococca saligna: a new class of cholinesterases inhibitors. Helv Chim Acta. 85:678–688.
  • Benn M, Jacyno JM. 1983. The toxicology and pharmacology of diterpenoid alkaloids. In: Pelletier SW, editor, Alkaloids: chemical and biological perspectives. New York: John Wiley & Sons. Vol. 1, p. 153–210.
  • Baytop T. 1999. Therapy with medicinal plants in turkey (past and present). Istanbul: Nobel Typ, Kitapevleri Press.
  • Choudhary MI. 1999. Recent studies on bioactive natural products. Pure Appl Chem. 71:1079–1081.
  • Darvesh S, Hopkins DA, Geula C. 2003. Neurobiology of butyrylcholinesterase. Nat Rev Neurosci. 4:131–138.
  • Duysen EG, Li B, Darvesh S, Lockridge O. 2007. Sensitivity of butyrylcholinesterase knockout mice to (-)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission. Toxicology. 233:60–69.
  • Ellman GL, Courtney KD, Andres V, Featherstone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7:88–95.
  • Farrugia LJ. 1999. WinGX suite for small-molecule single-crystal crystallography. J App Cryst. 32:837–838.
  • Greig NH, Utsuki T, Yu Q-s, Zhu X, Holloway HW, Perry T, Lee B, Ingram DK, Lahiri DK. 2001. A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase. Curr Med Res Opin. 17:159–165.
  • Grossberg GT. 2003 . Cholinesterase inhibitors for the treatment of Alzheimer's disease: getting on and staying on. Curr Ther Res Clin Exp. 64:216–235.
  • Jacquemin D, Perpete EA, Scuseria GE, Ciofini I, Adamo C. 2008 . TD-DFT performance for the visible absorption spectra of organic dyes: conventional versus long-range hybrids. J Chem Theory Comput. 4:123–135.
  • Lei J, Luo Y-J, Wang X-Q. 2011 . Talatisamine, a C(19)-diterpenoid alkaloid from Chinese traditional herbal ‘Chuanwu’. Acta Crystallogr Sect E Struct Rep Online. 67:o3145–o3146.
  • Mesulam M-M, Guillozet A, Shaw P, Levey A, Duysen E, Lockridge O. 2002. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience. 110:627–639.
  • Murray J. 1984. The plant and drug of Sindh. New Delhi: Ajay Book Service.
  • Perry E, Perry R, Smith C, Dick D, Candy J, Edwardson J, Fairbairn A, Blessed G. 1987. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatr. 50:806–809.
  • Raskin I, Ribnicky DM, Komarnytsky S, Ilic N, Poulev A, Borisjuk N, Brinker A, Moreno DA, Ripoll C, Yakoby N. 2002. Plants and human health in the twenty-first century. Trends Biotechnol. 20:522–531.
  • Raza M, Shaheen F, Choudhary M, Suria A, Rahman Au Sombati S, DeLorenzo R. 2001 . Anticonvulsant activities of the FS-1 subfraction isolated from roots of Delphinium denudatum. Phytother Res. 15:426–430.
  • Raza M, Shaheen F, Choudhary M, Rahman Au Sombati S, Suria A, Rafiq A, DeLorenzo R. 2003 . Anticonvulsant effect of FS-1 subfraction isolated from roots of Delphinim denudatum on hippocampal pyramidal neurons. Phytother Res. 17:38–43.
  • Renuga S, Muthu S. 2014 . Molecular structure, normal coordinate analysis, harmonic vibrational frequencies, NBO, HOMO-LUMO analysis and detonation properties of (S)-2-(2-oxopyrrolidin-1-yl) butanamide by density functional methods. Spectrochim Acta A Mol Biomol Spectrosc. 118:702–715.
  • Rocha JB, Emanuelli T, Pereira ME. 1993. Effects of early undernutrition on kinetic parameters of brain acetylcholinesterase from adult rats. Acta Neurobiol Exp (Wars). 53:431.
  • Sawatzky E, Wehle S, Kling B, Wendrich J, Bringmann G, Sotriffer CA, Heilmann J, Decker M. 2016. Discovery of highly selective and nanomolar carbamate-based butyrylcholinesterase inhibitors by rational investigation into their inhibition mode. J Med Chem. 59:2067–2082.
  • Shaheen F, Ahmad M, Anjum S, Rahman A, Fun H-K, Ahmad H, Choudhary M. 2004. 20-N-Ethyl-1, 8, 14-trihydroxy-16β, 18-dimethoxylycoctonine. Acta Crysta E: Struct Rep Online. 60:o774–o776.
  • Shaheen F, Ahmad M, Khan MTH, Jalil S, Ejaz A, Sultankhodjaev MN, Arfan M, Choudhary MI. 2005. Alkaloids of Aconitum laeve and their anti-inflammatory, antioxidant and tyrosinase inhibition activities. Phytochemistry. 66:935–940.
  • Shaheen F, Zeeshan M, Ahmad M, Anjum S, Ali S, Fun H-K, Choudhary MI. Atta-ur-Rahman 2006. Norditerpenoid alkaloids from Delphinium nordhagenii. J Nat Prod. 69:823–825.
  • Shaheen F, Ahmad M, Rizvi TS, Ali L. 2015. Norditerpenoid alkaloids from Delphinium kohatense Munz. Rec Nat Prod. 9:76–80.
  • Sheldrick GM. 2007. A short history of SHELX. Acta Crystallogr A. 64:112–122.
  • Tashkhodjaev B, Sultankhodjaev MN. 2007. 8b-Acetoxy-14a-benzoyloxy-N-ethyl-3a, 10b, 13b, 15a-tetrahydroxy-1a, 6a, 16b-trimethoxy-4b-(methoxymethylene)-aconitane: aconifine from Aconitum. Acta Crysta E. 65:o1543–o1544.
  • Wang H, Wang X, Wang H, Wang L, Liu A. 2007. DFT study of new bipyrazole derivatives and their potential activity as corrosion inhibitors. J Mol Mod. 13:147–153.
  • Yu Q-S, Holloway HW, Utsuki T, Brossi A, Greig NH. 1999. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease. J Med Chem. 42:1855–1861.
  • Zhang X. 2004. Cholinergic activity and amyloid precursor protein processing in aging and Alzheimer's disease. Curr Drug Targets CNS Neurol Disord. 3:137–152.
  • Zhang G, Musgrave CB. 2007. Comparison of DFT methods for molecular orbital eigenvalue calculations. J Phys Chem A. 111:1554–1561.